UPDATE 1-Novo launches Saxenda in US, sees more launches in 2015

April 22, 2015 1:42 PM

6 0

COPENHAGEN, April 22 (Reuters) - Novo Nordisk has launched its Saxenda obesity drug in the United States, it said on Wednesday, a long-awaited milestone that will provide a new revenue stream for the Danish drugmaker.

The company has said previously it expects sales from the drug to eventually reach $1 billion a year.

Also read: Casino Companies Seek Foothold in Georgia, the U.S.’s Last Big Untapped Gambling Market

Read more

To category page